These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33066343)

  • 21. Nature's second pandemic progress report.
    Nature; 2020 Oct; 586(7830):473-474. PubMed ID: 33087916
    [No Abstract]   [Full Text] [Related]  

  • 22. What China's speedy COVID vaccine deployment means for the pandemic.
    Cyranoski D
    Nature; 2020 Oct; 586(7829):343-344. PubMed ID: 33033397
    [No Abstract]   [Full Text] [Related]  

  • 23. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
    Yi C; Yi Y; Li J
    Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
    [No Abstract]   [Full Text] [Related]  

  • 24. Coronavirus disease-19 vaccine development utilizing promising technology.
    Wang Y; Xing M; Zhou D
    Curr Opin HIV AIDS; 2020 Nov; 15(6):351-358. PubMed ID: 32969973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'I've never worked harder': the race to develop a COVID-19 vaccine.
    Woolston C
    Nature; 2020 Nov; 587(7833):322. PubMed ID: 33168971
    [No Abstract]   [Full Text] [Related]  

  • 26. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 27. SARS-CoV-2 vaccines in development.
    Krammer F
    Nature; 2020 Oct; 586(7830):516-527. PubMed ID: 32967006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world.
    Sharpe HR; Gilbride C; Allen E; Belij-Rammerstorfer S; Bissett C; Ewer K; Lambe T
    Immunology; 2020 Jul; 160(3):223-232. PubMed ID: 32460358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects for a safe COVID-19 vaccine.
    Haynes BF; Corey L; Fernandes P; Gilbert PB; Hotez PJ; Rao S; Santos MR; Schuitemaker H; Watson M; Arvin A
    Sci Transl Med; 2020 Nov; 12(568):. PubMed ID: 33077678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?
    Fidel PL; Noverr MC
    mBio; 2020 Jun; 11(3):. PubMed ID: 32561657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can existing live vaccines prevent COVID-19?
    Chumakov K; Benn CS; Aaby P; Kottilil S; Gallo R
    Science; 2020 Jun; 368(6496):1187-1188. PubMed ID: 32527819
    [No Abstract]   [Full Text] [Related]  

  • 32. Efforts towards a COVID-19 vaccine.
    Brüssow H
    Environ Microbiol; 2020 Oct; 22(10):4071-4084. PubMed ID: 32893468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Super-rapid race for saving lives by developing COVID-19 vaccines.
    Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A
    J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering Vaccines for COVID-19: where do we stand today?
    Baviskar T; Raut D; Bhatt LK
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):8-21. PubMed ID: 33054486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Canaday DH; Gravenstein S
    Clin Infect Dis; 2021 Feb; 72(3):513-514. PubMed ID: 33527123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design.
    Chung YH; Beiss V; Fiering SN; Steinmetz NF
    ACS Nano; 2020 Oct; 14(10):12522-12537. PubMed ID: 33034449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus disease 2019 (COVID-19) vaccines: A concise review.
    Samaranayake LP; Seneviratne CJ; Fakhruddin KS
    Oral Dis; 2022 Nov; 28 Suppl 2():2326-2336. PubMed ID: 33991381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could live attenuated vaccines better control COVID-19?
    Okamura S; Ebina H
    Vaccine; 2021 Sep; 39(39):5719-5726. PubMed ID: 34426024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Science is There: Key Considerations for Stabilizing Viral Vector-Based Covid-19 Vaccines.
    Crommelin DJA; Volkin DB; Hoogendoorn KH; Lubiniecki AS; Jiskoot W
    J Pharm Sci; 2021 Feb; 110(2):627-634. PubMed ID: 33242452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Enlightening from optimizing post-authorization safety monitoring system of SARS-CoV-2 vaccines in major economies worldwide].
    Wang SY; Pan XJ; Deng X; Fu J; Zhang HJ; Ding LL; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):1096-1104. PubMed ID: 37482744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.